References 1 Rozga J et al . Human albumin : Old , new and emerging applications . Ann Transplant 2013 ; 18:205 – 17 . 2 Rabbani G , Ahn SN . Structure , enzymatic activities , glycation and therapeutic potential of human serum albumin : A natural cargo . Int J Biol Macromol 2019 ; 123:979 – 90 . 3 Arroyo V , Fernandez J . Pathophysiological basis of albumin use in cirrhosis . Ann Hepatol 2011 ; 10 ( Supp . 1 ): S6 – S14 . 4 Lee P , Wu X . Review : modifications of human serum albumin and their binding effect . Curr Pharm Des 2015 ; 21:1862 – 5 . 5 Arroyo V , Garcia-Martinez R , Salvatella X . Human serum albumin , systemic inflammation , and cirrhosis . J Hepatol 2014 ; 61:396 – 407 . 6 Scheiner B et al . Acid-base disorders in liver disease . J Hepatol 2017 ; 67:1062 – 73 . 7 Kamada T et al . Albumin prevents erythrocyte crenation in patients undergoing extracorporeal circulation . Scand J Thorac Cardiovasc Surg 1988 ; 22:155 – 8 . 8 Fisher J et al . Is heparinbinding protein inhibition a mechanism of albumin ’ s efficacy in human septic shock ? Crit Care Med 2018 ; 46 : e364-e374 . 9 Uchimido R et al . The glycocalyx : a novel diagnostic and therapeutic target in sepsis . Crit Care 2019 ; 23:16 . 10 Fernandez J et al . Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis . Gastroenterology 2019 ; 157 ( 1 ): 149 – 62 . 11 Duran-Güell M et al . Albumin protects the liver from tumor necrosis factor a-induced immunopathology . FASEB J 2021 ; 35 ( 2 ): e21365 . 12 Wheeler DS et al . The immunomodulatory effects of albumin in vitro and in vivo . Adv Pharmacol Sci 2011 ; 2011:691928 . 13 Aubin E et al . Immunomodulatory effects of therapeutic preparations of human albumin . Vox Sang 2011 ; 101:131 – 7 . 14 Garcovich M , Zocco MA , Gasbarrini A . Clinical use of albumin in hepatology . Blood Transfus 2009 ; 7 ( 4 ): 268 – 77 . 15 Jagdish RK , Maras JS , Sarin SK . Albumin in advanced liver diseases : The good and bad of a drug ! Hepatology 2021 ; Mar 27 [ Epub ahead of print ]. 16 Wong F et al . Terlipressin plus albumin for the treatment of Type 1 hepatorenal syndrome . N Engl J Med 2021 ; 384 ( 9 ): 818 – 28 . 17 Bern M et al . An engineered human albumin enhances half-life and transmucosal delivery when fused to proteinbased biologics . Sci Transl Med 2020 ; 12 ( 565 ): eabb0580
hospitalpharmacyeurope . com | 2023 | 9